Exact Sciences
EXAS
#1132
Rank
A$28.22 B
Marketcap
A$147.85
Share price
0.29%
Change (1 day)
101.84%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -A$1.56 Billion

According to Exact Sciences's latest financial reports the company's current earnings are A$3.08 Billion. In 2024 the company made an earning of -A$1.45 Billion a decrease over its 2023 earnings that were of -A$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.56 Billion7.48%
2024 -A$1.45 Billion435.05%
2023 -A$0.28 Billion-69.18%
2022 -A$0.88 Billion-25.77%
2021 -A$1.19 Billion1.68%
2020 -A$1.17 Billion271.17%
2019 -A$0.32 Billion58.99%
2018 -A$0.2 Billion20.89%
2017 -A$0.17 Billion-30.95%
2016 -A$0.24 Billion5.09%
2015 -A$0.23 Billion57.24%
2014 -A$0.15 Billion116.53%
2013 -A$66.09 Million
2011 -A$41.15 Million143.73%
2010 -A$16.89 Million27.85%
2009 -A$13.21 Million0.27%
2008 -A$13.17 Million-20.95%
2007 -A$16.66 Million-13.53%
2006 -A$19.27 Million-10.07%
2005 -A$21.43 Million-21.81%
2004 -A$27.41 Million-33.44%
2003 -A$41.17 Million-6.51%
2002 -A$44.04 Million17.95%
2001 -A$37.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$12.99 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$35.32 M-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$94.04 M-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-A$0.6 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$49.92 Million-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA